An ascending single and multiple dose study of the safety, tolerability, pharmacokinetics and anti-tumour activity of once-daily oral treatment with EO1001 in patients with advanced cancer

  • Frentzas, Sophia (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date8/07/21 → 7/07/26

Keywords

  • treatment safety
  • treatment efficacy
  • advanced cancer
  • pharmacokinetics